O'Reilly E - Search Results

1

Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.

Herman JM, Chang DT, Goodman KA, Dholakia AS, Raman SP, Hacker-Prietz A, Iacobuzio-Donahue CA, Griffith ME, Pawlik TM, Pai JS, O'Reilly E, Fisher GA, Wild AT, Rosati LM, Zheng L, Wolfgang CL, Laheru DA, Columbo LA, Sugar EA, Koong AC. Herman JM, et al. Cancer. 2015 Apr 1;121(7):1128-37. doi: 10.1002/cncr.29161. Epub 2014 Dec 23. Cancer. 2015. PMID: 25538019 Free PMC article. Clinical Trial.

2

A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesothelioma.

O'Reilly EM, Ilson DH, Saltz LB, Heelan R, Martin L, Kelsen DP. O'Reilly EM, et al. Cancer Invest. 1999;17(3):195-200. doi: 10.3109/07357909909021421. Cancer Invest. 1999. PMID: 10099658 Clinical Trial.

3

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.

Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, Schwartz GK, Casper ES. Fata F, et al. Cancer. 1999 Nov 15;86(10):2034-7. Cancer. 1999. PMID: 10570428 Clinical Trial.

4

A phase II study of irinotecan in patients with advanced hepatocellular carcinoma.

O'Reilly EM, Stuart KE, Sanz-Altamira PM, Schwartz GK, Steger CM, Raeburn L, Kemeny NE, Kelsen DP, Saltz LB. O'Reilly EM, et al. Cancer. 2001 Jan 1;91(1):101-5. doi: 10.1002/1097-0142(20010101)91:1<101::aid-cncr13>3.0.co;2-k. Cancer. 2001. PMID: 11148565 Clinical Trial.

5

Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancer.

Anderson SE, O'Reilly EM, Kelsen DP, Ilson DH. Anderson SE, et al. Cancer Invest. 2003;21(4):512-6. doi: 10.1081/cnv-120022360. Cancer Invest. 2003. PMID: 14533440 Clinical Trial.

6

A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.

Duffy A, Kortmansky J, Schwartz GK, Capanu M, Puleio S, Minsky B, Saltz L, Kelsen DP, O'Reilly EM. Duffy A, et al. Ann Oncol. 2008 Jan;19(1):86-91. doi: 10.1093/annonc/mdm441. Epub 2007 Sep 17. Ann Oncol. 2008. PMID: 17878176 Free article. Clinical Trial.

7

Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors.

Fornier MN, Rathkopf D, Shah M, Patil S, O'Reilly E, Tse AN, Hudis C, Lefkowitz R, Kelsen DP, Schwartz GK. Fornier MN, et al. Clin Cancer Res. 2007 Oct 1;13(19):5841-6. doi: 10.1158/1078-0432.CCR-07-1218. Clin Cancer Res. 2007. PMID: 17908977 Clinical Trial.

8

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.

Ku GY, Ilson DH, Schwartz LH, Capanu M, O'Reilly E, Shah MA, Kelsen DP, Schwartz GK. Ku GY, et al. Cancer Chemother Pharmacol. 2008 Oct;62(5):875-80. doi: 10.1007/s00280-008-0677-y. Epub 2008 Feb 13. Cancer Chemother Pharmacol. 2008. PMID: 18270704 Clinical Trial.

9

Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors.

Ku GY, O'Reilly EM, Saltz LB, Schrag D, Maki RG, Kelsen DP, Ilson DH. Ku GY, et al. Cancer Invest. 2009 May;27(4):402-6. doi: 10.1080/07357900802406327. Cancer Invest. 2009. PMID: 19219674 Clinical Trial.

10

Allergies, obesity, other risk factors and survival from pancreatic cancer.

Olson SH, Chou JF, Ludwig E, O'Reilly E, Allen PJ, Jarnagin WR, Bayuga S, Simon J, Gonen M, Reisacher WR, Kurtz RC. Olson SH, et al. Int J Cancer. 2010 Nov 15;127(10):2412-9. doi: 10.1002/ijc.25240. Int J Cancer. 2010. PMID: 20143395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

699 results

Search Page

Filters